PMC:7781431 / 489-839
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
32 | 33-43 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
37 | 192-198 | Chemical | denotes | lipids | MESH:D008055 |
38 | 216-224 | Chemical | denotes | lipoxins | MESH:D044045 |
39 | 226-235 | Chemical | denotes | resolvins | |
40 | 237-245 | Chemical | denotes | maresins | |
44 | 69-81 | Disease | denotes | inflammation | MESH:D007249 |
45 | 126-135 | Disease | denotes | mortality | MESH:D003643 |
46 | 324-336 | Disease | denotes | inflammation | MESH:D007249 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 44-58 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 26-136 | Sentence | denotes | In the SARS-CoV-2 cytokine storm, systemic inflammation has been associated with severe illness and mortality. |
T6 | 137-337 | Sentence | denotes | Recent studies have demonstrated special pro-resolving lipids mediators (SPMs) lipoxins, resolvins, maresins, and protectins as potential therapeutic options for abnormal viral-triggered inflammation. |